Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 QT and action potential duration.

× No keyword cloud information.

16 in total

1. The effects of amiodarone, an alpha and beta receptor antiagonist, on adrenergic transmission in the cat spleen.

Authors: Z M Bacq; A G Blakeley; R J Summers
Journal: Biochem Pharmacol Date: 1976-05-15 Impact factor: 5.858

2. Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

Authors: S B Olsson; L Brorson; E Varnauskas
Journal: Br Heart J Date: 1973-12

3. [Research on the benzofuran series. XL. Anti-arrhythmic properties of amiodarone].

Authors: R Charlier; G Delaunois; J Bauthier; G Deltour
Journal: Cardiologia Date: 1969

4. [Medical therapy of auricular flutter].

Authors: C Ferrero; M Benabderhamane
Journal: G Ital Cardiol Date: 1972

5. QT interval prolongation as predictor of sudden death in patients with myocardial infarction.

Authors: P J Schwartz; S Wolf
Journal: Circulation Date: 1978-06 Impact factor: 29.690

6. Effect of intravenous propranolol on QT interval. A new method of assessment.

Authors: J R Milne; A J Camm; D E Ward; R A Spurrell
Journal: Br Heart J Date: 1980-01

7. Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man.

Authors: N Edvardsson; S B Olsson
Journal: Br Heart J Date: 1981-06

8. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors: B N Singh; E M Vaughan Williams
Journal: Br J Pharmacol Date: 1970-08 Impact factor: 8.739

9. Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors.

Authors: R Charlier
Journal: Br J Pharmacol Date: 1970-08 Impact factor: 8.739

10. Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation.

Authors: E M Williams; M O Hassan; J S Floras; P Sleight; J V Jones
Journal: Br Heart J Date: 1980-11

10 in total

1. QT interval as a cardiac risk factor in a middle aged population.

Authors: J Karjalainen; A Reunanen; P Ristola; M Viitasalo
Journal: Heart Date: 1997-06 Impact factor: 5.994

2. Assessing SSRIs' effects on fetal cardiomyocytes utilizing placenta-fetus model.

Authors: Navein Arumugasaamy; Amelia Hurley-Novatny; Josephine Lembong; Peter C W Kim; John P Fisher
Journal: Acta Biomater Date: 2019-09-16 Impact factor: 8.947

3. Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart.

Authors: I D Dukes; E M Vaughan Williams
Journal: J Physiol Date: 1984-10 Impact factor: 5.182

4. The prolonged QT interval--a frequently unrecognized abnormality.

Authors: R A Kenny; R Sutton
Journal: Postgrad Med J Date: 1985-05 Impact factor: 2.401

Review 5. The management of acute poisoning due to beta-adrenoceptor antagonists.

Authors: J A Critchley; A Ungar
Journal: Med Toxicol Adverse Drug Exp Date: 1989 Jan-Feb

6. Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.

Authors: M C Allely; A Ungar
Journal: Br J Pharmacol Date: 1985-10 Impact factor: 8.739

7. Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region.

Authors: H O Gloor; F Urthaler; T N James
Journal: J Clin Invest Date: 1983-05 Impact factor: 14.808

Review 8. QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors: M Zehender; S Hohnloser; H Just
Journal: Cardiovasc Drugs Ther Date: 1991-04 Impact factor: 3.727

Review 9. Drug-induced torsade de pointes. Incidence, management and prevention.

Authors: T S Faber; M Zehender; H Just
Journal: Drug Saf Date: 1994-12 Impact factor: 5.606

10. Antiarrhythmic Drugs for Atrial Fibrillation: Selected Features of Ventricular Repolarization That Facilitate Proarrhythmic Torsades de Pointes and Favor Inpatient Initiation.

Authors: James A Reiffel
Journal: J Innov Card Rhythm Manag Date: 2021-07-15

10 in total